| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |